gut microbiota metabolism of l-carnitine and cardiovascular risk γ-Butyrobetaine Is a Proatherogenic Intermediate in Microbial to TMAO: Cell Metabolism Comparison of short-term and long-term
Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Microbiota in GutHeart Axis: Metabolites and Mechanisms in Cardiovascular Disease PMC Role of gut microbiota and derived metabolites in cardiovascular diseases ScienceDirect Gut microbiota and microbiota derived metabolites in cardiovascular diseases Chinese Medical Journal Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship
Pay in 4 interest-free payments of $6.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





